World Diabetes Congress press conference schedule
Monday, October 19, 2009
World Diabetes Congress Opening Press Conference
8:30 – 9:30 am EDT, Room 512 ae
Speakers: Prof Martin Silink, IDF President; Prof Jean Claude Mbanya, IDF Incoming President and Ms Ann Keeling, IDF CEO/Executive Director
IDF Diabetes Atlas Press Conference and Global Teleconference
12:30 - 1:30 pm EDT, Room 512 ae
Speakers: IDF Incoming President Prof Jean Claude Mbanya, Chair of the IDF Atlas Committee Prof Nigel Unwin and IDF Epidemiologist Dr David Whiting
What: launch of the 4th edition of this global resource featuring the latest diabetes prevalence figures, economic costs of diabetes, impact on development. 3rd edition is available free online.
This press conference is also available by teleconference. Journalists dialling in, please follow these instructions:
Telephone lines are open for media registration at 12 pm. The press conference will begin promptly at 12:30 pm.
International callers: +1 416-849-6163
North America Toll-Free: 1-866-250-5144
Tuesday, October 20, 2009
IDF Global Education Agenda Press Conference
11:00 a.m. – 12 p.m. EDT, Room 512ae
Speakers: IDF Senior Vice President Marg McGill, IDF Consultative Section on Education members Anne Belton and Martha Funnell
What: launch of the IDF International Curriculum for Diabetes Health Professional Education and IDF International Standards for Diabetes Education and presentation IDF’s global education agenda.
Industry press conference
Celebration of Education IDF/CDA/Lilly Diabetes Symposium: Conversation Map™ education tools demonstration
Media demonstrations with diabetes experts, 20 October 2009, 18:30 – 19:30
Hall 517A, 5th Floor, The Palais des Congrès de Montréal Conference Centre.
Media contact: Daphne Hoytt, MS&L, daphne.hoytt@mslworldwide.com, +1 212-468-3558
Wednesday, October 21, 2009
IDF Impact Study Results Press Conference
1 pm – 2 pm EDT (13:00-14:00), Room 512 ae
Speakers: Dr Jonathan Betz Brown, Chair of the IDF Health Economics Task Force and Senior Investigator at the Kaiser Permanente Center for Health Research; Dr Kaushik Ramaiya, IDF Vice President and lead on Africa Study results; Dr JJ Gagliardino, member of the IDF Health Economics Task Force and lead on Argentina Impact Study Results and Dr. W. Yang is lead investigator of the IDF Impact Studies in China (TBC).
What: launch of the International Diabetes Federation study results from Africa, Argentina and China.
Industry press conferences
T-fal Cooking Demonstration
20 October 2009 – 12:00 – 3:00 p.m. EDT, Room 512b
Media contact: Paola Colzani, T-fal, paola.colzani@sprim.com, +1 214-443-0723
Intensifying Expectations: Assessing Unmet Needs in Diabetes Management
Novo Nordisk media briefing, Wednesday, 21 October, 14.30-15.45
Room 512ae, The Palais des Congrès de Montréal Conference Centre
Media Contact: RSVP to Lindsay Evans. Email: Lindsay.Evans@edelman.com Tel: +44 (0)7843 392 028.
Thursday, October 22, 2009
Meet the President Press Briefing
9 am – 10 am, Room 512b
Speaker: Incoming IDF President Jean-Claude Mbanya
What: Jean Claude Mbanya will serve as IDF President from 2009-12. He will discuss his vision for the triennium; IDF’s role in responding to the diabetes epidemic and diabetes impact on Africa.
IDF Global Guidelines Press Conference and Teleconference
11:15 a.m. – 12:15 p.m. EDT, Room 512ae
Speakers: Dr Stephen Colagiuri – chair of the IDF Task Force on Clinical Practice Guidelines; Dr David Owen, author of the IDF Self-Monitoring of Blood Glucose Guidelines; Dr Lois Jovanovic, author of the IDF Pregnancy and Diabetes Guidelines and Dr Massimo Massi-Benedetti, IDF Vice President and author of the IDF Oral Health Guidelines.
What: launch of the IDF Global Guidelines on SBMG, Pregnancy, Oral Health and presentation of the Type 1 and Type 2 Guidelines (TBC).
This press conference is also available by teleconference. Journalists dialling in, please follow these instructions:
Telephone lines are open for media registration at 11:00 a.m. The press conference begins promptly at 11:15 a.m.
International callers: +1-416-849-6163
North America Toll-Free: +1-866-250-5144